4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-253459
Chief Executive Officer sold 12,837 shares at $69.74 ($895,252)
- Chief Executive Officer gave 300,000 shares (gift)
- Chief Executive Officer gave 300,000 shares (gift)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BELANOFF JOSEPH K · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-29 | Gift : show line 1 in the form 10b5-1 | −300,000 | 2,578,326 | I | ||
| 2026-05-29 | Gift : show line 2 in the form 10b5-1 | +150,000 | 150,000 | I | ||
| 2026-05-29 | Gift : show line 3 in the form 10b5-1 | +150,000 | 150,000 | I | ||
| 2026-06-01 | Sale : show line 4 in the form 10b5-1 | −12,837 | $69.74 | $895,252 | 2,565,489 | I |
| Open-market sales · 12,837 sh · avg $69.74 · $895,252 | ||||||
Loading xslF345X06/ownership.xml…